Background: The optimal management and prognostic factors of postsurgical pulmonary vein stenosis remain controversial. We sought to determine current postsurgical pulmonary vein stenosis outcomes and prognostic factors in a multicentric study in the current era.
Postsurgical pulmonary vein stenosis (PSPVS) is defined as pulmonary vein stenosis (PVS) occurring secondarily after a cardiac surgical procedure. PSPVS can occur after many types of cardiac surgery and is particularly common after repair of total anomalous pulmonary venous drainage, affecting 10% to 17% of patients. 1, 2 Pulmonary vein (PV) restenosis, reintervention, and mortality rates after surgical repair of PSPVS remain high. The concept of the sutureless technique for PVS repair avoiding the suture of the veins themselves was introduced in the mid-1990s. [3] [4] [5] [6] This technique was presented as real progress in some early reports, [7] [8] [9] while appearing disappointing in the more recent ones, [10] [11] [12] [13] [14] [15] [16] especially in the series focusing on patients with congenital PVS. [11] [12] [13] 15, 17 The outcomes of this technique in the specific population of PSPVS and risk factors for poor outcomes are still controversial because series are often limited and heterogeneous. We sought to determine current outcomes after surgical repair for PSPVS and prognostic factors in a large multicentric study focusing on PSPVS treated in the current era.
PATIENTS AND METHODS Patient Inclusion and Data Collection
Patients included in this study are those in whom PSPVS developed, as defined earlier, and who then underwent at least 1 surgical repair of PSPVS in a participating institution between January 1, 2000, and January 1, 2013. Fourteen European or North American institutions were enrolled in this retrospective study. We did not include (1) patients with primary PVS, (2) patients with normal PVs at birth who then developed a PVS without any prior surgery, and (3) patients with PSPVS who were not treated (n ¼ 1) or who were treated by a percutaneous procedure or a pneumonectomy as an initial procedure (n ¼ 3). The collection of data regarding patient characteristics, PVS characteristics, types of surgical procedures, and outcomes was approved by each hospital's local committee on clinical investigation and was performed according to a common and uniform database to ensure consistency. Hospital records were reviewed in each center, and follow-up data were obtained by contacting the treating cardiologists. Studied end points were (1) PSPVS-related death, (2) persistence or recurrence of moderate (echographic mean gradient 5-7 mm Hg) or severe (echographic mean gradient >7 mm Hg) stenosis of at least 1 vein, and (3) PV reintervention or PSPVS-related death. Severe pulmonary hypertension was defined in this study as pulmonary artery pressure greater than 3/4 systemic pressure.
Severity Score
A specific PVS severity score was previously developed by our group. 16 Briefly, the assessment of each vein was based on echocardiography before each procedure in all cases, strengthened by angiography, computed tomography (CT) scan and magnetic resonance imaging (MRI) in 52%, 9%, and 7% of cases, respectively. This score is based on (1) the degree of the stenosis evaluated by the echographic pressure gradient measured at the venoatrial junction, (2) the focal/diffuse aspect of the stenosis evaluated by the combined imaging modalities mentioned above, and (3) the unilateral/bilateral feature of the disease. The absence of stenosis was defined by the absence of PV narrowing, a biphasic blood flow, and a mean echo gradient less than 2 mm Hg. Mild, moderate, and severe stenosis were defined by a mean echo gradient of 2 to 4 mm Hg, 5 to 7 mm Hg, and greater than 7 mm Hg, respectively. The stenosis was described as ''focal'' when affecting a very short length of the PV and associated with upstream dilatation of the PV. The stenosis was ''diffuse'' when affecting a significant length of the PV with no upstream dilation of the PV. The assignment of numbers for each PV (range, 0-4) to the score (range, 0-18) is described in Table 1 . All imaging reports were completed by experienced cardiologists in each center, independently of the outcome of the PV procedure. There were no missing data. PVS scores were then established by a single observer, independently of the outcome of the PV procedure. The postoperative PVS score was defined at the time of hospital discharge.
Surgery
The different types of surgical procedures are described in the ''Results'' section. Of note, in the resection-type sutureless technique, the PV pathologic tissue was totally resected along with a part of the left atrial wall. When an endoveinectomy was performed, stenosed veins were opened longitudinally to go beyond the level of the stenosis (as proximally as possible), and the surgeon excised the fibrotic tissue in the area.
Data Analysis
Data analysis was performed with SAS software (version 9.4, SAS Institute Inc, Cary, NC). Data are expressed as median with interquartile range (IQR) or mean AE standard deviation. The comparison of percentages was achieved with the chi-square test or Fisher exact test for qualitative variables. Comparison of means and medians was performed using the Student t test or Mann-Whitney U test. Actuarial freedom curves from mortality, PV recurrence, and PV reintervention/mortality were analyzed according to the Kaplan-Meier estimates with 95% confidence intervals. A univariate analysis of time-related end points was achieved with the log-rank test and the univariate Cox model for continuous variables. The multivariate Cox model was used for the multivariable analysis of time-related end points. Variables that were found to be associated with the 3 studied end points with a P value less than .1 in the univariate analysis or that had clinical relevance were included in the logistic models. The covariates in the multivariate Cox analysis include age, gender, weight, postoperative PSV severity score, and sutureless procedure. Because the postoperative PVS severity score was a time-varying covariate during the observation time, it was added into the Cox model as a time-dependent variable. Calibration of the logistic model was assessed using the Hosmer-Lemeshow goodnessof-fit test to evaluate the discrepancy between observed and expected values. Hazard ratios (HRs) were expressed with 95% confidence intervals.
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GLM The linearity in the logit assumption and proportional hazards assumption was assessed and met. Given the continuous response variable of postoperative PVS severity score, we used the generalized linear model (GLM) with negative binomial distribution to estimate if the choice of surgical procedure (sutureless vs nonsutureless) resulted in a lower PVS severity score at the time of hospital discharge. The covariates in the GLM include age, gender, weight, preoperative PSV severity score greater than 8.5, diffuse aspect of PVS, single ventricle, bilateral disease, dispersion, and sutureless procedure. All the tests were 2-sided. Analysis of variance was used to compare PVS scores before and after the repair. Predictive accuracy for the obtained PVS score value was assessed by calculating the area under the receiver operating characteristics curve, and model calibrations and fit were assessed with Hosmer-Lemeshow goodness-of-fit statistics.
RESULTS
Demographic, Anatomic, and Surgical Characteristics A total of 75 patients with PSPVS underwent 103 procedures. Demographic, anatomic, and surgical characteristics are presented in Table 2 . The mean age at the procedure was 5 months (IQR, 0-184). Twenty-six patients had a single ventricle physiology. Sixty-two percent of patients had a bilateral disease, and half of the patients had a diffuse stenosis of at least 1 PV. The median preoperative severity score was 8.0 (IQR, 5.0-12.0). A PVS score greater than 8.5 and greater than 9 had the best predictive accuracy for PV restenosis (area under the curve 0.63) and PV reintervention or death (area under the curve 0.61), respectively. There were no significant differences in the preoperative severity of the disease between the sutureless and nonsutureless groups ( Table 2 ). The PV repair followed a previous repair of total anomalous pulmonary venous return (TAPVR) in 58 patients (77%) and a previous repair of a non-TAPVR cardiac surgery in 17 patients (23%).
The types of sutureless procedures (n ¼ 42) and nonsutureless procedures (n ¼ 61) are described in Table 2 . PV plasty was performed in 51 procedures using a patch of autologous pericardium (n ¼ 24), polytetrafluoroethylene (n ¼ 9), or appendage tissue (n ¼ 3), and using no patch in 15 patients. Median patient follow-up was 29 months (IQR, 5-72 months).
Surgical Outcomes
A global overview of the outcomes is presented in Figure 1 and Table 3 (univariable analysis) . Overall mortality, PV reintervention/mortality, and PV restenosis occurred in 27% (n ¼ 20/75), 49% (n ¼ 50/103), and 56% (n ¼ 58/ 103), respectively. The descriptive analysis shows significant difference of postoperative PVS score at discharge between the sutureless procedure and the nonsutureless procedure (mean 3.04 vs 5.87, P ¼ .0048; median 0.00 vs 5.00, P ¼ .0049). The postoperative severity score at discharge, the severity score at last follow-up, and the postoperative improvement of the PVS score at discharge after sutureless procedures were all significantly better compared with after nonsutureless procedures (P ¼ .0048, P ¼ .0025, and P ¼ .02) ( Table 3) . A plot showing the values of the PVS severity score before surgery, after surgery at discharge, and at last follow-up for each patient is presented in Figure 2 , B. Sutureless repair was associated with less restenosis (40% vs 67%; P ¼ .007) and less reintervention (31% vs 61%; P ¼ .003) compared with nonsutureless procedures at last follow-up (Table 3 ). The mortality rate after sutureless repair (20%; 7/35) tended to be lower than after nonsutureless repair (33%; 13/40) but was not statistically significant (P ¼ .22) ( Table 3) . Kaplan-Meier actuarial curves for the 3 end points are presented in Figures 2  and 3 . Freedom from mortality, reintervention, and restenosis at 5 years of follow-up were 71% AE 10%, 55% AE 11%, and 56% AE 11%, respectively (Figure 3 ). Restenosis occurred in the first postoperative year in the majority of cases, with a median delay of 3.3 months (range, 1 month to 5 years). Reintervention-free survival at 5 years was significantly lower in patients who had a nonsutureless repair (42% vs 68%; P ¼ .049) (Figure 2, A) and postoperative pulmonary hypertension (11% vs 83%; P ¼ .0001).
Results of the univariate analysis are shown in Table 4 . Factors significantly associated with PV restenosis, reintervention, or mortality are low weight at surgery, female gender, use of a nonsutureless procedure, and a high postoperative severity score at the time of hospital discharge (all P<.05).
The GLM multivariate analysis showed that the choice of sutureless procedure reduced the postoperative PVS severity score by 0.4346 and P ¼ .2249, conditional on the demographic and clinical characteristic (age, gender, weight, preoperative PSV severity score >8.5, diffuse aspect of PVS, single ventricle, bilateral disease, and dispersion).
Multivariate analysis (Table 4) showed that a high postoperative residual PVS score at the time of hospital discharge was an independent risk factor for restenosis (HR, 1.55; P < 10 À4 ), reintervention (HR, 1.33; P<10 À4 ) and mortality (HR, 1.37; P<10 À4 ). The sutureless technique was an independent protective factor against restenosis (HR, 0.27; P ¼ .006). 
DISCUSSION
To our knowledge, this study is the largest series of patients with PSPVS published in the literature. This study shows that PSPVS still has a guarded prognosis in the current era with high rates of restenosis, PV reintervention, and mortality. The sutureless technique used for PSPVS is associated with a lower risk of PV restenosis and reintervention and may tend to reduce the risk of mortality. The sutureless technique is an independent protective factor against restenosis. The severity of the residual disease evaluated by a new severity score is an independent risk factor for poor outcomes regardless of surgical technique.
Reported recurrence, reintervention, and mortality rates after repair of PSPVS remain high in the literature. [10] [11] [12] 14, 15, [18] [19] [20] [21] [22] Toronto's group and Boston's group recently reported in 2015 an actuarial survival of 60% to 64% between 2 and 5 years after surgery despite a large experience in PVS treatment. 14, 20 Our multicentric series focusing on patients treated for PSPVS in the current era Patient-related factors associated with poor outcomes still remain controversial in the literature because of the small sample size of previous studies. 10, 14, 19, 23 Of note, young age at procedure, prematurity, single ventricle anatomy, genetic anomalies, and heterotaxy syndrome are not associated with poor outcomes in our series. Overall, these patient-related demographic and genetic factors, which are common risk factors for patients with other severe congenital heart diseases, seem to have little or no impact in this specific population of PSPVS. This could be explained by the major role played by the intrinsic severity of the PVS disease, which can mask the potential impact of other factors. Of note, female gender was associated with poorer outcomes, which will need to be confirmed by other studies.
The intrinsic severity of the disease before or after the procedure appears to be the most decisive factor determining final outcomes, not only in congenital PVS 11, 12, 16 but also in PSPVS, as shown in the present series. A high postoperative PVS score at the time of hospital discharge is an independent risk factor of PV restenosis, reintervention, and death. A greater number of stenotic PVs has been shown to be associated with an increased risk of death, especially when there is bilateral involvement in some series of PSPVS. 19, 24, 25 The only 5 independent predictors of mortality demonstrated so far in the literature in multivariate analysis (high preoperative PVS score by Viola and colleagues, 12 involvement of greater than 3 PV and progression to uninvolved PVs by Song and colleagues, 11 and postoperative high PVS score and pulmonary hypertension 1 month after surgery by Kalfa and colleagues 16 ) were shown in series focusing on congenital PVS. The multivariable analysis in our series confirms that the severity of the residual disease and the adequacy of the surgical PV decompression at the time of hospital discharge are the main determinants of late outcomes in patients with PSPVS.
The impact of the specific PVS score that our group described for the population of congenital PVS 16 seems to remain true in the population of PSPVS. The impact of this score emphasizes the major role played by the severity of the residual disease after surgery compared with the score described by the Toronto group. 8, 12 The PVS score used in the present study takes into account the focal/ diffuse aspect of each PVS and the bilateral aspect of the disease. Despite the inherent limitations of echocardiography to assess the PV ''upstream'' in the lung parenchyma, this score showed a good predictive accuracy for PV restenosis (cutoff >8.5) and reintervention (cutoff >9).
The sutureless procedure has been based on the concept of reducing trauma to the veins in hopes of reducing any stimulus for regrowth of obstructive tissue. This technique initially led to promising results, 3, 5, 6 including improved survival in some series, 4, 8, 9, 26, 27 but most recent series reported disappointing outcomes, [10] [11] [12] [13] [14] [15] 17, 25 especially in children with primary PVS 7, 11, 12, 15, 16 or those with single ventricle anatomy. 26 Toronto's group showed that the sutureless technique to repair post-TAPVR PSPVS improved survival and reduced need for reinterventions, 5, 8 but in contrast has been largely ineffective in the patients with primary PVS. 12 Although not showing any positive impact of the sutureless repair in our previously published series of patients with congenital PVS, 16 we demonstrate in the present series focusing on PSPVS that the sutureless technique was associated with a lower risk of PV restenosis and reintervention and may tend to reduce the risk of mortality in this different population of patients (univariate analysis). We also show in the multivariate analysis that the sutureless technique is an independent protective factor against PV restenosis.
Study Limitations
This study is limited by its retrospective nature, with its inherent risks of selection bias, retrospective suboptimal data collection, and the absence of a fully centralized imaging core laboratory. The multicentric aspect of this study led to a significant heterogeneity of patients and decisionmaking processes regarding imaging and interventions that were not based on protocols. Patients in the nonsutureless group tended to have a higher preoperative PVS severity score and more single ventricle defects. Although these variables were not statistically significant, when taken as a whole in the setting of relatively few outcome events, these differences could account for some of the differences between the groups. The operator-dependent aspect of surgical PV procedures could not be taken into account in the multivariate analysis because of the large number of participating institutions and surgeons and the variability of patients enrolled per institution. The PVS-related morbidity and neurodevelopment-related outcomes and quality of life of patients were not assessed in this study. The PVS score described was based on retrospective echocardiographic data, included too sparse data from CT and MRI, and still needs to be validated in a prospective study. Indeed, in this retrospective study, angiography, CT, and MRI were obtained in 52%, 9%, and 7%, respectively, before surgery and 24%, 14%, and 11%, respectively, after surgery. Overall, 62% of patients had nonechocardiographic imaging before the procedure and 38% of patients had imaging after surgery. This nonsystematic use of additional imaging modalities may introduce a bias into the comparison of preoperative and postoperative PVS severity scores. Finally, histologic specimen and genetic studies would have been of major interest to investigate further the mechanisms at work in this complex disease but could not be performed for logistical reasons.
CONCLUSIONS
Postsurgical PVS still has a guarded prognosis in the current era. The sutureless technique used for acquired PSPVS is an independent protective factor against PV restenosis. The severity of the residual disease evaluated by a new severity score is an independent risk factor for poor outcomes regardless of surgical technique.
